References
- Faille GA, Gill VJ, Fischer SH (1999). Optimal activation of isopsoralen to prevent amplicon carryover. I Clin Micorbiol, 37: 261–262.
- Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997). Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349: 241–244.
- Mina SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41, 479–486.
- Pevenstein SR, Williams RK, McChesney D, Mont EK, Smialek JE, Straus SE (1999). Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J. Virol, 73: 10514–10518.
- Tsuang D, Kukull W, Sheppard L, Barnhart RL, Peskind E, Edland SD, Schellenberg G, Raskind M, Larson EB (1996). Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples. I Am Geriatr Soc, 44: 704–707.
- Wu YY, Delgado R, Costello R, Sunderland T, Dukoff R, Csako G (2000). Quantitative assessment of apolipo-protein E genotypes by image analysis of PCR-RFLP fragments. Clin Chim Acta, 293: 213–221.